References
Baumann CR (2017) Wide implications of a trial on pitolisant for cataplexy. Lancet Neurology; published 24 January, DOI: http://dx.doi.org/10.1016/S1474-4422(16)30398-2
Billiard M, Bassetti C, Dauvilliers Y et al. (2006) EFNS guidelines on management of narcolepsy. European Journal of Neurology 13(10): 1035–48
Dauvilliers Y, Bassetti C, Lammers GJ et al. for the HARMONY I study group (2013) Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurology 12(11): 1068–75
Sateia MJ (2014) International classification of sleep disorders-third edition: highlights and modifications. Chest 146(5): 1387–94
Szakacs Z, Dauvilliers Y, Mikhaylov V et al. for the HARMONY-CTP study group (2017) Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial. Lancet Neurology; published 24 January, DOI: http://dx.doi.org/10.1016/S1474-4422(16)30333-7